Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ChemDiv, Inc. Highlights Successful Deployment of Proprietary CNS Drug Discovery Platform, Advancing Neurodegenerative Programs for Polku Therapeutics and Brenig Therapeutics
-
Transactions in connection with share buy-back program
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Focus Graphite Announces SEDAR+ Filing of the NI 43-101 Technical Report with the Updated Mineral Resource for the Lac Tetepisca Project
-
Nuvion × Visa Direct: Expanding Real-Time Money Movement for Businesses Globally
-
Breakthrough Study Shows Exclzyme Pet™ Supports Joint Health in 92% of Dogs
-
Hisense Showcases "Innovating a Brighter Life" Message at FIFA World Cup 2026™
-
Havas Reports the Progress of Transactions Under Its Current Share Buyback Program
-
BidMachine Introduces Direct Placements and Agentic Readiness
-
Data on debtor composition
-
American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
-
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
-
Power Knot Launches WMX++ Water System to Optimize Performance of a Downstream Process
-
BitDelta Pro selects Iress to power multi-asset trading platform
-
AL Sydbank A/S share buyback programme: transactions in week 25
-
Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall
-
Preliminary data on early redemptions (prepayments)
-
Envision Energy Unveils 2026 Net Zero Action Report at VivaTech, Pioneering Future Energy Systems for Civilizational Prosperity
-
Moldova Digital Summit 2026: EU Commissioner Marta Kos Praises Moldova as a Digital Success Story
-
Telia Lietuva acquired frequencies for 5G network for almost EUR 10 million
-
STARTRADER Delivers Emergency Relief to 300 Earthquake-Affected Families in the Philippines
-
Form 8.3 - [ANIMALCARE GROUP PLC - 19 06 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 19 06 2026] - (CGWL)
-
Joey Chandler of Certain Growth Solutions Develops Values-Based System for Consistent Growth
-
H3 Zoom Closes Oversubscribed USD$3.6 Million Series A Round to Scale AI-Powered Inspection Intelligence Across Asia
-
Transactions in connection with share buyback programme
-
Neotech Metals Approved for $500,000 CMIF Grant
-
Navan Invests in European Footprint with New Partnerships
-
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802
-
Carmed Pharmaceuticals Shares Tips for Maintaining Wellness During Summer Travel
-
Northern Trust Appointed to Support TirNua Capital Partners’ Inaugural Infrastructure Fund
-
Finalists Announced for the Second Edition of the Reply AI Music Contest, the International Competition Exploring the Relationship Between AI and Live Performance
-
AM Best to Join Panel Discussion at 2026 Azerbaijan International Insurance Forum
-
Over 50% of Brands Have Adopted Agentic AI, Yet High-Value Customer Journeys Remain in Manual Limbo, Infobip Report Finds
-
CSG showcased new projects, partnerships and key portfolio products at Eurosatory 2026
-
Danske Bank share buy-back programme: transactions in week 25
-
Rena Striegel of Transition Point Business Advisors Highlights Early Warning Signs in Farm Transitions
-
Retailers Lose £29 Million to Returns Fraud Across 1 Million Orders, as New ReBound Data Reveals Industry "Blind Spot"
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Prosafe SE: Operational update – May 2026
-
TECNO Introduces CAMON Slim: Ultra-Slim Art Piece in Hand with Diverse Mood Light and Practical AI
-
Clariane has launched a proposed offering of €333 million of undated deeply subordinated hybrid notes to refinance its ODIRNANE
-
Xilam Films Greenlights Feature Adaptation of The Wolf with Bidibul Productions, Goodfellas, ARP and Crunchyroll on Board
-
A New Era in Medical Tourism: Patients Are No Longer Choosing Only the Treatment, but the System That Manages It
-
Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
-
Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
-
Sonilo Launches Licensed AI Music Generator for Video on fal.ai
